|
|
Article: Natural Immune Evolution, The Symphogen Way.
- Article from:
- BIOWORLD Today
- Article date:
- November 3, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Bioworld Today Columnist
A few years back, Kirsten Drejer, director of Novo Nordisk's diabetes discovery research, got a call from a former co-worker inviting her to join a group of ex-Novo folks who were looking for an entrepreneurial opportunity. They had a team and an interest in fully human antibodies as therapeutics.
At the 2000 Annual BIO conference in Boston, Drejer heard Jacqueline Sharon of Boston University talk about generating recombinant human polyclonal antibodies (PAbs) against infectious diseases. That sounded like an entrepreneurial science to go with that team. But wait, you say, isn't monoclonal (MAb) the way to go - a highly ...